Effect of Sodium Glucose Co-Transporter 2 Inhibitor Use on Anthropometric Measurements and Blood Glucose in Obese and Non-Obese Type 2 Diabetic Patients

Obesity and type 2 diabetes mellitus are closely associated with each other and require careful management. This study aimed to assess the impact of sodium-glucose co-transporter 2 (SGLT2) inhibitors on glycemic control and body composition in diabetic patients, stratified by obesity status.